Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - MERIDIAN BIOSCIENCE INC | d787840dex312.htm |
| EX-31.1 - EX-31.1 - MERIDIAN BIOSCIENCE INC | d787840dex311.htm |
| EX-10.4 - EX-10.4 - MERIDIAN BIOSCIENCE INC | d787840dex104.htm |
| EX-10.3 - EX-10.3 - MERIDIAN BIOSCIENCE INC | d787840dex103.htm |
| EX-10.2 - EX-10.2 - MERIDIAN BIOSCIENCE INC | d787840dex102.htm |
| EX-10.1 - EX-10.1 - MERIDIAN BIOSCIENCE INC | d787840dex101.htm |
| 10-Q - 10-Q - MERIDIAN BIOSCIENCE INC | d787840d10q.htm |
Exhibit 32
Meridian Bioscience, Inc.
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing with the Securities and Exchange Commission of the Quarterly Report of Meridian Bioscience, Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2020 (the “Report”), the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| /s/ Jack Kenny |
| Jack Kenny |
| Chief Executive Officer |
| February 5, 2021 |
| /s/ Bryan T. Baldasare |
| Bryan T. Baldasare |
| Executive Vice President and Chief Financial Officer |
| February 5, 2021 |